Ethnic disparities in melanoma diagnosis and survival
|
|
- Sharleen Stafford
- 5 years ago
- Views:
Transcription
1 Ethnic disparities in melanoma diagnosis and survival The effects of socioeconomic status and health insurance coverage Amy M. Anderson-Mellies, MPH 1 Matthew J. Rioth, MD 1,2,3 Myles G. Cockburn, PhD 1,4,5,6 1University of Colorado Comprehensive Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO; 2 Division of Biomedical Informatics and Personalized Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO; 3 Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO; 4 Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO; 5 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA; 6 Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA
2 The big picture Stage Distribution for Melanomas by Ethnicity, 2008 to Five-Year Melanoma-Specific Survival Rates (%) by Ethnicity, 2005 to Percent 50 Percent Localized Regional Distant Unknown Male Female Hispanic NHW Hispanic NHW Data source: Cancer statistics for Hispanics/Latinos, 2015, Volume: 65, Issue: 6, Pages: , First published: 16 September 2015, DOI: ( /caac.21314)
3 Some possible explanations Advanced stage Screening Thicker tumors Biology Hispanic Nodular & Acral Lentiginous melanomas Poorer prognosis Low SES Medicaid & Uninsured Access to Care
4 The Big Question Are Hispanic disparities in melanoma diagnosis and survival explained by modifiable factors rather than by tumor characteristics or other unmeasured biological factors?
5 Methods Data source: California Cancer Registry Study population: Non-Hispanic White (NHW) and Hispanic patients diagnosed with invasive cutaneous melanoma between 1995 and 2014 Variables: Age, sex, race/ethnicity, neighborhood socioeconomic status (SES), insurance status, SEER summary stage, histology, and anatomic site Outcomes: Late (regional or distant) stage at diagnosis and melanoma-related death (survival)
6 Tumor Characteristics Male Female NHW Hispanic NHW N=70,895 N=2,828 N=46,081 Hispanic N=3,729 Stage* Localized 83.0% 65.6% 86.9% 78.9% Regional 8.2% 17.0% 6.6% 10.9% Distant 4.7% 10.8% 3.0% 5.2% Unstaged 4.0% 6.6% 3.6% 4.9% Histology* Malignant melanoma, NOS 54.5% 53.9% 54.7% 52.4% Superficial spreading melanoma 25.8% 20.2% 29.9% 28.8% Nodular melanoma 7.3% 11.0% 5.9% 7.5% Lentigo maligna melanoma 5.7% 3.6% 3.9% 2.3% Acral lentiginous melanoma 0.5% 5.6% 0.8% 4.3% Other 6.2% 5.7% 4.8% 4.7% Anatomic Site* Limbs 31.4% 39.8% 58.0% 57.6% Head/Neck 26.3% 23.2% 14.5% 15.4% Trunk 37.5% 28.3% 24.1% 22.1% Other 4.8% 8.7% 3.4% 4.9% *p<.001
7 SES and insurance Male Female NHW N=70,895 Hispanic N=2,828 NHW N=46,081 Hispanic N=3,729 Age at Diagnosis (mean)* 63.6 yrs 58.1 yrs 58.4 yrs 52.1 yrs Socioeconomic Status* Highest SES 34.6% 14.8% 32.9% 15.4% Higher-middle SES 24.9% 16.8% 25.6% 20.3% Middle SES 18.3% 19.5% 19.4% 20.7% Lower-middle SES 12.0% 22.2% 12.6% 19.8% Lowest SES 5.7% 22.8% 5.7% 20.4% Unknown 4.5% 3.9% 3.8% 3.4% Insurance Status* Private 48.3% 43.7% 54.3% 51.9% Medicaid 2.0% 11.6% 2.4% 9.9% Medicare 28.4% 22.5% 22.7% 15.2% Military 3.1% 1.7% 0.9% 0.6% Insured, NOS 5.8% 4.6% 6.7% 5.5% Uninsured 1.5% 5.0% 1.4% 3.8% Unknown 10.8% 10.9% 11.6% 13.2% *p<.001
8 Late-stage disparities (males) Male, Hispanic Male, NHW Socioeconomic Status Insurance Status Histology Percent diagnosed at regional/distant stage * ALM (acral lentiginous melanoma), LMM (lentigo maligna melanoma), NM (nodular), SSM (superficial spreading), MM(NOS) malignant melanoma not otherwise specified
9 Late-stage disparities (females) Female, Hispanic Female, NHW Socioeconomic Status Insurance Status Histology Percent diagnosed at regional/distant stage * ALM (acral lentiginous melanoma), LMM (lentigo maligna melanoma), NM (nodular), SSM (superficial spreading), MM(NOS) malignant melanoma not otherwise specified
10 Putting it all in one model Hispanic Higher-middle SES Middle SES Lower-middle SES Lowest SES Medicaid Uninsured SSM NM LMM ALM Other * Referent groups are NHW, 0.0 MM(NOS), private insurance, 4.0and highest SES. Model 8.0 also adjusts for age, sex, and 12.0 anatomic site Adjusted* Odds Ratio
11 So There s something about being Hispanic (over and above tumor characteristics, lower SES and insurance coverage) that increases risk of being diagnosed with late stage disease
12 10 year 82.5% ( ) 71.3% ( ) 89.0% ( ) 85.7% ( ) What about survival? Survival Male, NHW Male, Hispanic Female, NHW Female, Hispanic 1 year 95.8% ( ) 92.2% ( ) 97.3% ( ) 96.4% ( ) 5 year 86.7% ( ) 77.6% ( ) 91.7% ( ) 88.3% ( )
13 What explains survival differences? Model Hazard Ratio Unadjusted 1.39 ( ) Adjusted for age and sex 1.72 ( ) Adjusted for above and: Stage Histologic type Anatomic site Adjusted for above and: SES Insurance status 1.14 ( ) 0.93 ( )
14 Probability of death Hispanic Higher-middle SES Middle SES Lower-middle SES Lowest SES Medicaid Uninsured Regional Distant SSM NM LMM ALM Other *Referent groups are NHW, localized stage, MM(NOS), private insurance, and highest SES. Model also adjusts for age, sex, and anatomic site. Adjusted* Hazard Ratio
15 Summary Hispanics with melanoma are more likely to be diagnosed at a late stage even after accounting for SES, insurance status, histology, and anatomic site. Hispanics have an overall 72% increased risk of death from melanoma, and a 14% increased risk after considering stage at diagnosis and tumor characteristics However, accounting for SES and insurance status explains the remaining increased risk of death observed among Hispanics.
16 Conclusions 1. Later stage at diagnosis for Hispanics could be due to knowledge of risk and attitudes towards screening (not able to be explained by tumor characteristics nor SES/insurance) Plenty of evidence that Hispanics underestimate their risk of skin cancer, and don t think screening is important. Late stage disease results in substantial morbidity, long term health effects, loss of job etc, especially problematic among lower SES individuals Results in (avoidable) system-wide health care expenses, especially for Medicaid/Medicare
17 Conclusions 2. Poor Hispanic melanoma survival is attributable to: Presenting with melanoma at a late stage (so we need to fix #1!!) Insurance status and SES rather than ethnicity or tumor characteristics (which means they are preventable) o Ability to get to treatment? o Ability to stick with treatment? o Transportation and other barriers?
18 Conclusions 3. Improvements in Hispanic melanoma survival could be achieved by focusing on diagnosing Hispanic patients earlier. 4. More work is required to determine what barriers there are to melanoma diagnosis for Hispanics, and to determine if those barriers are also relevant to obtaining the appropriate follow-up care after diagnosis (survival).
19 Acknowledgements This work was supported in part by the Population Health Shared Resource of the University of Colorado Comprehensive Cancer Center funded by the National Cancer Institute grant P30CA The collection of cancer incidence data used in this study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section ; Centers for Disease Control and Prevention s (CDC) National Program of Cancer Registries, under cooperative agreement 5NU58DP /DP003862; the National Cancer Institute s Surveillance, Epidemiology and End Results Program under contract HHSN C awarded to the Cancer Prevention Institute of California, contract HHSN C awarded to the University of Southern California, and contract HHSN C awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the author(s) and do not necessarily reflect the opinions of the State of California, Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors.
20 Questions?
Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment
Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment Makenzie L. Hawkins, MSPH 1 Matthew J. Rioth, MD 1,2 Megan M. Eguchi, MPH 1 Myles Cockburn, Phd
More informationRacial differences in six major subtypes of melanoma: descriptive epidemiology
Wang et al. BMC Cancer (2016) 16:691 DOI 10.1186/s12885-016-2747-6 RESEARCH ARTICLE Racial differences in six major subtypes of melanoma: descriptive epidemiology Yu Wang 1, Yinjun Zhao 2 and Shuangge
More informationUsing Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure
Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure Meg Watson, MPH Epidemiologist NAACCR Annual Conference June 16, 2016 National Center for Chronic Disease
More informationCalifornia Medicaid Enrollment and Melanoma Stage at Diagnosis A Population-Based Study
California Medicaid Enrollment and Melanoma Stage at Diagnosis A Population-Based Study Ricardo A. Pollitt, PhD, Christina A. Clarke, PhD, MPH, Sarah J. Shema, MS, Susan M. Swetter, MD Background: Methods:
More informationMelanoma Among Blacks in the United States MaryBeth Freeman, MPH ORISE Fellow
Melanoma Among Blacks in the United States MaryBeth Freeman, MPH ORISE Fellow NAACCR Annual Conference June 13, 2018 Data Visualizations Tool U.S. Cancer Statistics www.cdc.gov/cancer/dataviz Public Use
More informationCancer Prevention Institute of California, Fremont, California. 2. Stanford Cancer Institute, Stanford, California. 3
How much of the racial/ethnic disparities in cancer survival in California is explained by differences in tumor, sociodemographic, institutional and neighborhood characteristics? Elizabeth Ellis 1,2, Alison
More informationCUTANEOUS MALIGNANT MELANOMA AMONG WHITE HISPANICS AND NON-HISPANICS
CUTANEOUS MALIGNANT MELANOMA AMONG WHITE HISPANICS AND NON-HISPANICS IN THE UNITED STATES Aim: To explore whether disparities exist in melanoma incidence and prognosis between White Hispanics and White
More informationA post-psa Update on Trends in Prostate Cancer Incidence. Ann Hamilton and Myles Cockburn Keck School of Medicine, USC, Los Angeles
A post-psa Update on Trends in Prostate Cancer Incidence Ann Hamilton and Myles Cockburn Keck School of Medicine, USC, Los Angeles Background 1986: FDA approved PSA test to monitor disease status in prostate
More informationMelanoma Surveillance in the United States: Overview of Methods
Melanoma Surveillance in the United States: Overview of Methods Meg Watson, MPH Epidemiologist Epidemiology and Applied Research Branch Division of Cancer Prevention and Control Centers for Disease Control
More informationPatient and Hospital Characteristics Associated with Nephron-Sparing Surgery for Small, Localized Kidney Cancers in California,
Patient and Hospital Characteristics Associated with Nephron-Sparing Surgery for Small, Localized Kidney Cancers in California, 2012-2015 Brenda M. Giddings, M.A. California Cancer Reporting and Epidemiologic
More informationThe Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012
The Cancer Burden in California Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012 Goals Introduce you to the California Cancer Registry (CCR) Provide an
More informationKatsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe
Akita J Med 36 : 45-52, 2009 45 Katsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe (Received 22 December 2008, Accepted 15 January 2009)
More informationSurvival among Native American Adolescent and Young Adult Cancer Patients in California
Survival among Native American Adolescent and Young Adult Cancer Patients in California Cyllene R. Morris, 1 Yi W. Chen, 1 Arti Parikh-Patel, 1 Kenneth W. Kizer, 1 Theresa H. Keegan 2 1 California Cancer
More information1 Cancer Council Queensland, Brisbane, Queensland, Australia.
Title: Diagnosis of an additional in situ does not influence survival for patients with a single invasive : A registry-based follow-up study Authors: Danny R Youlden1, Kiarash Khosrotehrani2, Adele C Green3,4,
More informationScarlett Gomez, MPH, PhD Cancer Prevention Institute of California NAACCR 2017 conference, Albuquerque NM June 2017
The influence of socioeconomic status and ethnic enclave on endometrial cancer mortality among Hispanic and Asian American/Pacific Islander women in California Scarlett Gomez, MPH, PhD Cancer Prevention
More informationMelanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU
Melanoma Underwriting Presented at 2018 AHOU Conference Hank George FALU MELANOMA EPIDEMIOLOGY 70-80,000 American cases annually Majority are in situ or thin > 20% are diagnosed age 45 8-9,000 melanoma
More informationAdjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study
COLON CANCER ORIGINAL RESEARCH Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study Rosemary D. Cress 1, Susan A. Sabatino 2, Xiao-Cheng Wu 3,
More information6/20/2012. Co-authors. Background. Sociodemographic Predictors of Non-Receipt of Guidelines-Concordant Chemotherapy. Age 70 Years
Sociodemographic Predictors of Non-Receipt of Guidelines-Concordant Chemotherapy - among Locoregional Breast Cancer Patients Under Age 70 Years Xiao-Cheng Wu, MD, MPH 2012 NAACCR Annual Conference June
More informationCancer Liaison Physician Report Standard 4.3, 4.4, 4.5 Years of data is from Melanoma 2013
Cancer Liaison Physician Report Standard 4.3, 4.4, 4.5 Years of data is from 2-21 Melanoma 213 With the Annual Report for 214 on Melanoma, Dr. Konrad the Cancer Liaison Physician for the Mercy Cancer Committee
More information12. Malignant Melanoma of Skin
KEY FACTS 12. Malignant Melanoma of Skin ICD-9 172 On average 160 melanomas of the skin were registered per year. Twice as common in females than in males. Higher than expected numbers in Southern Board
More informationLaboratory for Quantitative Medicine Technical Report #2 April 10, Equation Parameters
Laboratory for Quantitative Medicine Technical Report #2 April 10, 2009 Equation Parameters This report summarizes all the equation parameters used by the web-based calculators, and provides information
More informationGeographic Variation of Advanced Stage Colorectal Cancer in California
Geographic Variation of Advanced Stage Colorectal Cancer in California Jennifer Rico, MA California Cancer Registry California Department of Public Health NAACCR 2016- St. Louis, MO June 16, 2016 Overview
More informationColorectal Cancer in Idaho November 2, 2006 Chris Johnson, CDRI
Colorectal Cancer in Idaho 2002-2004 November 2, 2006 Chris Johnson, CDRI cjohnson@teamiha.org Colorectal Cancer in Idaho, 2002-2004 Fast facts: Colorectal cancer is the second leading cause of cancer
More informationChanging Incidence of Hodgkin Lymphoma Histologic Subtypes: Risk Factor Trends or Evolving Diagnostic Practice?
Changing Incidence of Hodgkin Lymphoma Histologic Subtypes: Risk Factor Trends or Evolving Diagnostic Practice? Greater Bay Area Cancer Registry Cancer Prevention Institute of California Stanford Cancer
More informationClinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 124 Japanese Patients
Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 24 Japanese Patients Yoshie Kuno, Kazuyuki Ishihara, Naoya Yamazaki and Kiyoshi Mukai 2 'Dermatology Division
More informationSpending estimates from Cancer Care Spending
CALIFORNIA HEALTHCARE FOUNDATION August 2015 Estimating Cancer Care Spending in the California Medicare Population: Methodology Detail This paper describes in detail the methods used by Deborah Schrag,
More informationSTUDY. Incidence and Survival Patterns in the United States,
STUDY Acral Lentiginous Melanoma Incidence and Survival Patterns in the United States, 1986-2005 Porcia T. Bradford, MD; Alisa M. Goldstein, PhD; Mary L. McMaster, MD; Margaret A. Tucker, MD Objective:
More informationTreatment disparities for patients diagnosed with metastatic bladder cancer in California
Treatment disparities for patients diagnosed with metastatic bladder cancer in California Rosemary D. Cress, Dr. PH, Amy Klapheke, MPH Public Health Institute Cancer Registry of Greater California Introduction
More informationConstruction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts
Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Chris Johnson, Cancer Data Registry of Idaho NAACCR 2016 Annual Conference June 14, 2016 Concurrent
More informationLinking Oncotype Dx results to SEER data and patient report to assess challenges in individualizing breast cancer care
Linking Oncotype Dx results to SEER data and patient report to assess challenges in individualizing breast cancer care June 16, 2015 NAACCR, Charlotte, NC Ann Hamilton, Ph.D. Keck School of Medicine, University
More informationChapter 5: Epidemiology of MBC Challenges with Population-Based Statistics
Chapter 5: Epidemiology of MBC Challenges with Population-Based Statistics Musa Mayer 1 1 AdvancedBC.org, Abstract To advocate most effectively for a population of patients, they must be accurately described
More informationAn Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center
An Overview of Melanoma Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center Melanoma Statistics Median age at presentation 45-55 55 years Incidence: 2003 54,200 cases
More informationIdentifying Geographic & Socioeconomic Disparities in Access to Care for Pediatric Cancer Patients in Texas
Identifying Geographic & Socioeconomic Disparities in Access to Care for Pediatric Cancer Patients in Texas Mary T. Austin, MD, MPH Assistant Professor, Pediatric Surgery University of Texas Health Science
More informationThyroid Cancer in New Mexico
Thyroid Cancer in New Mexico Time Trends and Surgical Treatment Preferences Ihsan Mahdi MD MPH Introduction The incidence of thyroid cancer incidence is increasing more rapidly than any other malignancy
More informationSTUDY. CME available online at
STUDY Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program Anne M. Lachiewicz, MPH;
More informationCutaneous Melanoma Incidence and Survival Among Black, Asian and Pacific Islander and White Populations in the United States
Clinical Medicine Insights: Dermatology Original Research Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Cutaneous Melanoma Incidence and Survival Among,
More informationSuggested Citation: Copyright Information:
This report was prepared by the CalCARES Program, Institute for Population Health Improvement, UC Davis Health System, for the Chronic Disease Surveillance and Research Branch, California Department of
More informationCharacteristics of Philadelphia Census Tracts with High Prostate Cancer Risk
Characteristics of Philadelphia Census Tracts with High Prostate Cancer Risk Charnita Zeigler-Johnson, PhD, MPH Thomas Jefferson University Philadelphia, PA Using Cancer Registry Data in Disparities Research
More informationExamining Racial Differences in Utilization of Genetic Counseling Services in Hereditary Cancer Network Database
Examining Racial Differences in Utilization of Genetic Counseling Services in Hereditary Cancer Network Database Taylor Seaton, MS Cancer Genomics Epidemiologist MDHHS Cancer Genomics Program: Lifecourse
More informationCharacteristics, treatment patterns, and survival outcomes of primary GI melanoma cases compared to cutaneous melanoma, SEER:
Characteristics, treatment patterns, and survival outcomes of primary GI melanoma cases compared to cutaneous melanoma, SEER:1973-2015 Amanda Kahl, MPH Mary E. Charlton, PhD, Imran Hassan, MD, Paolo Goffredo,
More informationSpringer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone
Concise Reference Staging and Diagnosing Cutaneous Melanoma Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Extracted from Handbook of Cutaneous Melanoma: A Guide to Diagnosis and Treatment Published
More informationImpact of Poor Healthcare Services
Competency 3 Impact of Poor Healthcare Services Updated June 2014 Presented by: Lewis Foxhall, MD VP for Health Policy Professor, Clinical Cancer Prevention UT MD Anderson Cancer Center Competency 3 Objectives
More informationColorectal Cancer Screening
Tool 2.1 Cancer Screening Basic Fact Sheet Are You at High Risk? Your risk for colorectal cancer may be higher than average if: stomach You or a close relative have had colorectal polyps or colorectal
More informationEpidemiology DATA AND METHODS
British Journal of Cancer () 9, 91 9 All rights reserved 7 9/ $3. www.bjcancer.com Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in
More informationNew York State Oral Cancer Partnership
New York State Oral Cancer Partnership Jayanth V. Kumar, DDS MPH New York State Department of Health Gustavo D. Cruz, DDS, MPH New York University College of Dentistry 1 Objectives Develop an organizational
More informationResearch Article Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin s Lymphoma
Journal of Cancer Epidemiology Volume 2010, Article ID 824691, 10 pages doi:10.1155/2010/824691 Research Article Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults
More informationMalignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes: Part 1 Deba P Sarma, MD., Omaha The melanocytic tumor is one of the most difficult and confusing areas in Dematopathology. It is true that most (95%) of such lesions are
More informationOverview of Gynecologic Cancers in New Jersey
Overview of Gynecologic Cancers in New Jersey New Jersey State Cancer Registry Antoinette M. Stroup, PhD presented at: Gynecologic Cancer Symposium: Striving for a Healthier Tomorrow, Today November 19,
More informationCancer in Los Angeles County:
Cancer in Los Angeles County: Survival among Adolescents and Young Adults 988-204 USC/Norris Comprehensive Cancer Center Keck School of Medicine University of Southern California Cancer in Los Angeles
More informationTime Course and Pattern of Metastasis of Cutaneous Melanoma Differ between Men and Women
Time Course and Pattern of Metastasis of Cutaneous Melanoma Differ between Men and Women Liljana Mervic 1,2 * 1 Department of Dermatology, Center of Dermatooncology, University of Tüebingen, Germany, 2
More informationMelanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media
Melanoma and Dermoscopy Richard P. Usatine, MD, FAAFP Professor, Family and Community Medicine Professor, Dermatology and Cutaneous Surgery Medical Director, University Skin Clinic University of Texas
More informationMalignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases
Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases Faruk Tas, Sidika Kurul, Hakan Camlica and Erkan Topuz Institute of Oncology, Istanbul University, Istanbul, Turkey Received
More informationAccess to insurance and stage of cervical cancer in Massachusetts
Access to insurance and stage of cervical cancer in Massachusetts Sarah Feldman MD, MPH Brigham and Women s Hospital Department of Gynecologic Oncology Boston, MA USA Co-Authors: Michelle Davis MD, Colleen
More informationMISSING IN ACTION : Ethnic Groups in Cancer Screening
MISSING IN ACTION : Ethnic Groups in Cancer Screening Annette E. Maxwell, Dr.P.H. Division of Cancer Prevention and Control Research Jonsson Comprehensive Cancer Center University of California, Los Angeles
More informationMelanoma Thickness Trends in the United States,
ORIGINAL ARTICLE in the United States, 26 Vincent D. Criscione 1,2 and Martin A. Weinstock 1,2 Over the past two decades, numerous efforts have been initiated to improve screening and early detection of
More informationSurvival Difference between Non-Hispanic Black and Non-Hispanic White Women with Localized Breast Cancer: The Impact of Guideline-Concordant Therapy
o r i g i n a l c o m m u n i c a t i o n Survival Difference between Non-Hispanic Black and Non-Hispanic White Women with Localized Breast Cancer: The Impact of Guideline-Concordant Therapy Xiaocheng
More informationJohan Lyth, J Hansson, C Ingvar, E Mansson-Brahme, P Naredi, U Stierner, G Wagenius and C Lindholm. Linköping University Post Print
Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark s level of invasion: results of a population-based study from the Swedish Melanoma Register Johan
More informationSetting the stage for change: upgrading the physician cancer case reporting application in New York
Setting the stage for change: upgrading the physician cancer case reporting application in New York April Austin New York State Cancer Registry (NYSCR) July 12, 2018 June 13, 2018 Aerial view of Thousand
More informationIncidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho
Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho 2008-2011 August 2013 A Publication of the Cancer Data Registry of Idaho PO
More informationProtocol applies to melanoma of cutaneous surfaces only.
Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC
More informationBREAST CANCER IN IDAHO
BREAST CANCER IN IDAHO 1997-2001 1 2 3 4 5 7 6 Non-Hospital Mammography Facilities Idaho Hospitals Health Districts Idaho County Boundaries This PowerPoint presentation was created as a collaborative effort
More informationDavid B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma
Common Medicolegal Situations: Misdiagnosis of Melanoma David B. Troxel, MD Medical Director, The Doctors Company, Napa, California Clinical Professor Emeritus, University of California at Berkeley Past
More informationIncreasing Burden of Melanoma in the United States
ORIGINAL ARTICLE Increasing Burden of Eleni Linos,2, Susan M. Swetter 2,3,4, Myles G. Cockburn 5, Graham A. Colditz 6 and Christina A. Clarke,4 It is controversial whether worldwide increases in melanoma
More informationHealth Policy Research Brief
July 2010 Health Policy Research Brief Mental Health Status and Use of Mental Health Services by California Adults David Grant, Nicole Kravitz-Wirtz, Sergio Aguilar-Gaxiola, William M. Sribney, May Aydin
More informationMalignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the
More informationCutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.
Cutaneous Malignancies: A Primer Marissa Heller, M.D. Associate Director of Dermatologic Surgery Department of Dermatology Beth Israel Deaconess Medical Center December 10, 2016 Skin Cancer Non-melanoma
More informationMOLECULAR ANALYSIS OF A SERIES OF ACRAL MELANOMAS IN SINGAPORE
MOLECULAR ANALYSIS OF A SERIES OF ACRAL MELANOMAS IN SINGAPORE PoYin Tan Inny Busmanis Dept of Anatomical Pathology, Lynette Oon Head, Molecular Lab Singapore General Hospital ETHNIC GROUPS IN SINGAPORE
More informationResearch Article Melanoma in Buckinghamshire: Data from the Inception of the Skin Cancer Multidisciplinary Team
Skin Cancer Volume 2013, Article ID 843282, 6 pages http://dx.doi.org/10.1155/2013/843282 Research Article Melanoma in Buckinghamshire: Data from the Inception of the Skin Cancer Multidisciplinary Team
More informationSuggested Citation: Production and design by Magdalena Burgos.
This report was prepared by the CalCARES Program, Institute for Population Health Improvement, UC Davis Health System, for the Chronic Disease Surveillance and Research Branch, California Department of
More informationThe Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study
The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study Robert R. German, DrPH, MPH; Tim Byers, MD, MPH; Holly Wolf, PhD, MSPH; Jen Wike, MBA, MPH; Linda Alley,
More informationMelanoma. Kaushik Mukherjee MD A. Scott Pearson MD
Melanoma Kaushik Mukherjee MD A. Scott Pearson MD Disclosures You still have to study Not all inclusive No Western blots Extensive use of Google Image Search and Sabiston Melanoma Basics 8 th most common
More informationTrends in Pneumonia and Influenza Morbidity and Mortality
Trends in Pneumonia and Influenza Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Health Education Division November 2015 Page intentionally left blank Introduction
More informationIMPACT OF AREA-POVERTY RATE ON LATE-STAGE COLORECTAL CANCER INCIDENCE IN INDIANA, NAACCR JUNE 22, 2017
IMPACT OF AREA-POVERTY RATE ON LATE-STAGE COLORECTAL CANCER INCIDENCE IN INDIANA, 2010-2014 NAACCR JUNE 22, 2017 Aaron Cocke, Amanda K. Raftery, Timothy McFarlane SECTION 1 OVERVIEW OF PROJECT Purposes
More informationAccuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa:
Accuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa: 2010-2014 Amanda Kahl, MPH Mary Charlton, PhD, Nitin Pagedar, MD, MPH, Steven Sperry,
More informationEmerging Issues in Cancer Prevention and Control
Emerging Issues in Cancer Prevention and Control Marcus Plescia, MD, MPH Director, Division of Cancer Prevention and Control Centers for Disease Control & Prevention National Center for Chronic Disease
More informationILI Syndromic Surveillance
ILI Syndromic Surveillance Race/ethnicity of adult respondents with influenza-like illness (ILI) in the U.S., Behavioral Risk Factor Surveillance System (BRFSS), Sept 1- Sep 30, 2009 Race/ethnicity I
More informationDisparities in Progress against Cancer in the USA
Disparities in Progress against Cancer in the USA Ahmedin Jemal, DVM, PhD American Cancer Society ASPO Webinar November 29, 2018 Progress in reducing cancer death rates in the US, 1970-2015 240 220 215
More informationComparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet Exposure
Comparison of Melanoma Subtypes in Korean Patients Ann Dermatol Vol. 26, No. 4, 2014 http://dx.doi.org/10.5021/ad.2014.26.4.485 ORIGINAL ARTICLE Comparison of Melanoma Subtypes among Korean Patients by
More informationDr. Brent Doolan, BSc MBBS MPH
Impact of partial biopsies on the need for complete excisional surgery in the management of cutaneous melanomas: A multi-centre review Dr. Brent Doolan, BSc MBBS MPH Peter MacCallum Cancer Centre, Melbourne
More informationIncidence of Primary Liver Cancer in American Indians and Alaska Natives
Incidence of Primary Liver Cancer in American Indians and Alaska Natives Stephanie C. Melkonian, PhD Epidemiologist Epidemiology and Applied Research Branch NAACCR Annual Conference June 21, 2017 Overview
More informationCDC HPV Typing of Cancers Study: Evaluating Representativeness
CDC HPV Typing of Cancers Study: Evaluating Representativeness NAACCR Annual Conference June 22, 2011 Meg Watson, MPH National Center for Chronic Disease Prevention and Health Promotion Division of Cancer
More informationMetropolitan and Micropolitan Statistical Area Cancer Incidence: Late Stage Diagnoses for Cancers Amenable to Screening, Idaho
Metropolitan and Micropolitan Statistical Area Cancer Incidence: Late Stage Diagnoses for Cancers Amenable to Screening, Idaho 26-29 December 2 A Publication of the CANCER DATA REGISTRY OF IDAHO P.O. Box
More informationAnnual Report to the Nation on the Status of Cancer, , Featuring Survival Questions and Answers
EMBARGOED FOR RELEASE CONTACT: Friday, March 31, 2017 NCI Media Relations Branch: (301) 496-6641 or 10:00 am EDT ncipressofficers@mail.nih.gov NAACCR: (217) 698-0800 or bkohler@naaccr.org ACS Press Office:
More informationDermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH
Dermatological Manifestations in the Elderly Sanjay Siddha Staff Dermatologist UHN & MSH Disclosure No actual or potential conflicts of interest or commercial relationships to declare Objectives Recognize
More informationAddressing the Problem of Health Literacy: Practical Approaches in Practice
Addressing the Problem of Health Literacy: Practical Approaches in Practice Darren DeWalt, MD, MPH & Michael Pignone, MD, MPH University of North Carolina-Chapel Hill Department of Medicine Topics Relationship
More informationAcknowledgements and Disclaimer
Infant Cancers in California, 1988 2011 Acknowledgements and Disclaimer The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of
More informationInternational Journal of Scientific & Engineering Research, Volume 8, Issue 8, August-2017 ISSN ,956
1,956 Differences in survival by race/ethnicity among cutaneous melanoma patients in the United States over a period of thirty years (1982-2011) Abdulrahman M Nasiri 1, Elharith S Al-Akeel 1. 1College
More informationMapping late-stage breast cancer rates for community-based cancer screening interventions
Mapping late-stage breast cancer rates for community-based cancer screening interventions Anna Loraine Agustin, MPH, Zul Surani, Jaehyun Shin, MPH, Andrew Curtis, PhD, Lourdes Baezconde-Garbanati, PhD
More informationAcral Melanoma in Japan
Acral Melanoma in Japan MAKOTO SEUI, M.D., HIDEAKI TAKEMATSU, M.D., MICHIKO HOSOKAWA, M.D., MASAAKI OBATA, M.D., YASUSHI TOMITA, M.D., TAIZO KATO, M.D., MASAAKI TAKAHASHI, M.D., AND MARTIN C. MIHM, JR.,
More informationAYA Cancer: The Lost Tribe
AYA Cancer: The Lost Tribe Date: February 22, 2010 Leah Kroon, MN, RN None 1. Discuss why AYA cancer outcomes are not keeping up with pediatric and/or adult cancer patient outcomes 2. Identify special
More informationCancer in Los Angeles County CANCER
Cancer in Los Angeles County CANCER SURVEILLANCE PROGRAM BIBLIOGRAPHY 1972-2013 Prepared by Dennis Deapen, Dr.P.H. Lenard C. Berglund, D.M.A. LOS ANGELES CANCER SURVEILLANCE PROGRAM UNIVERSITY OF SOUTHERN
More informationCHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO
OHIO MEDICAID ASSESSMENT SURVEY 2012 Taking the pulse of health in Ohio CHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO Amy Ferketich, PhD Ling Wang, MPH The Ohio State University College of Public Health
More informationINTRODUCTION TO CANCER STAGING
INTRODUCTION TO CANCER STAGING Patravoot Vatanasapt, MD Dept. Otorhinolaryngology Khon Kaen Cancer Registry Faculty of Medicine Khon Kaen University THAILAND Staging is the attempt to assess the size
More informationRare melanoma: Are the options improving? Dr Neil Steven Consultant in Medical Oncology University Hospital Birmingham University of Birmingham
Rare melanoma: Are the options improving? Dr Neil Steven Consultant in Medical Oncology University Hospital Birmingham University of Birmingham Classifying melanoma Melanoma (site of origin, thickness,
More informationThey can develop anywhere on the skin and also inside the mouth. They can develop in normal skin or where there is an existing skin mole.
What are malignant melanomas? Malignant melanomas are one type of skin cancer. They can develop anywhere on the skin and also inside the mouth. They can develop in normal skin or where there is an existing
More informationClinical characteristics
Skin Cancer Fernando Vega, MD Seattle Healing Arts Clinical characteristics Precancerous lesions Common skin cancers ACTINIC KERATOSIS Precancerous skin lesions Actinic keratoses Dysplastic melanocytic
More informationRyan White Program Demographic Data Fiscal Year 25
Total # of Clients Ryan White Program Demographic Data Fiscal Year 25 (3/1/2015 thru 2/29/2016) (June 6, 2016) Review of Utilization Data from the Service Delivery Information System (SDIS) Prepared by
More informationMalignant melanoma (MM) is primarily a. Epidemiology of melanoma in Puerto Rico,
Epidemiology of melanoma in Puerto Rico, 1987-2002 SHEILA M. VALENTÍN, MD*; JORGE L. SÁNCHEZ, MD ; LUZ D. FIGUEROA, MD ; CRUZ M. NAZARIO, Ph D** Background: The incidence of cutaneous malignant melanoma
More informationMultiple Primary Melanoma in a Thai Male: A Case Report
Case Report Multiple Primary Melanoma in a Thai Male: A Case Report J Med Assoc Thai 2014; 97 (Suppl. 2): S234-S238 Full text. e-journal: http://www.jmatonline.com Kittisak Payapvipapong MD*, Pinyapat
More information